Terveystalo
8.76 EUR +0.34%10,923 investors are following this company
Terveystalo operates in the healthcare sector. The company offers services and solutions that, for example, concern surveys and examinations, education and coaching, rehabilitation, and health and fitness mapping. The customers are found among small and medium-sized corporate customers, as well as among actors in the public sector. The head office is located in Helsinki.
P/E (24e)
13.37
EV/EBIT (adj.) (24e)
12.35
P/B (24e)
1.96
Dividend yield-% (24e)
3.65 %
Target price
9.20 EUR
Recommendation
Accumulate
Updated
29.4.2024
NASDAQ Helsinki
TTALO
Daily low / high price
8.72 / 8.82
EUR
Market cap
1.11B EUR
Turnover
370.47K EUR
Volume
42K
Business risk
Valuation risk
Current
Previous
Analyst
Roni Peuranheimo
Analyst
Latest videos
Financial calendar
Interim report
17.07.2024
Half year dividend
08.10.2024
Interim report
25.10.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Varma Mutual Pension Insurance Company | 17.4 % | 17.4 % |
Rettig Group Ab | 16.7 % | 16.7 % |
Premium
This content is for our Premium customers only.
Insider Transactions
Insider | Date | Total value |
---|---|---|
Juuso Pajunen | 31.10.2023 | 16,771EUR |
Juuso Pajunen | 07.08.2023 | 14,420EUR |
Premium
This content is for our Premium customers only.
Income statement
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Revenue | 986.4 | 1,154.6 | 1,259.1 | 1,286.5 | 1,332.1 | 1,369.3 | 1,401.6 | 1,434.6 |
growth-% | -4.3 % | 17.1 % | 9.0 % | 2.2 % | 3.5 % | 2.8 % | 2.4 % | 2.4 % |
EBITDA | 158.0 | 198.1 | 168.9 | 179.1 | 214.9 | 237.7 | 242.9 | 244.8 |
EBIT (adj.) | 93.0 | 128.9 | 88.4 | 104.7 | 132.5 | 149.0 | 153.4 | 155.9 |
EBIT | 67.2 | 110.1 | 33.9 | -14.7 | 110.5 | 134.5 | 141.2 | 144.7 |
Profit before taxes | 56.7 | 100.4 | 31.0 | -38.9 | 82.8 | 108.9 | 119.8 | 128.2 |
Net income | 45.9 | 80.0 | 24.5 | -42.2 | 65.6 | 86.0 | 94.7 | 101.2 |
EPS (adj.) | 0.52 | 0.74 | 0.54 | 0.54 | 0.66 | 0.77 | 0.82 | 0.87 |
growth-% | -11.5 % | 42.9 % | -27.8 % | -0.1 % | 22.3 % | 17.3 % | 7.0 % | 5.5 % |
Dividend | 0.26 | 0.28 | 0.28 | 0.30 | 0.32 | 0.34 | 0.36 | 0.38 |
Dividend ratio | 72.5 % | 44.8 % | 145.1 % | -90.2 % | 62.0 % | 50.2 % | 48.3 % | 47.7 % |
Profitability and return on capital
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
EBITDA-% | 16.0 % | 17.2 % | 13.4 % | 13.9 % | 16.1 % | 17.4 % | 17.3 % | 17.1 % |
EBIT-% (adj.) | 9.4 % | 11.2 % | 7.0 % | 8.1 % | 9.9 % | 10.9 % | 10.9 % | 10.9 % |
EBIT-% | 6.8 % | 9.5 % | 2.7 % | -1.1 % | 8.3 % | 9.8 % | 10.1 % | 10.1 % |
ROE | 8.2 % | 13.6 % | 4.1 % | -7.6 % | 12.1 % | 14.6 % | 14.8 % | 14.6 % |
ROI | 5.9 % | 9.6 % | 2.9 % | -1.3 % | 9.7 % | 12.0 % | 12.7 % | 13.1 % |
Valuation
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Share price (EUR) | 10.04 | 11.84 | 6.25 | 7.74 | 8.76 | 8.76 | 8.76 | 8.76 |
Shares | 128.0 | 128.0 | 127.0 | 127.0 | 127.0 | 127.0 | 127.0 | 127.0 |
Market cap | 1,285.5 | 1,516.0 | 793.8 | 983.3 | 1,112.8 | 1,112.8 | 1,112.8 | 1,112.8 |
Enterprise value | 1,777.1 | 2,035.2 | 1,360.6 | 1,581.3 | 1,637.1 | 1,577.4 | 1,516.3 | 1,454.7 |
EV/S | 1.8 | 1.8 | 1.1 | 1.2 | 1.2 | 1.2 | 1.1 | 1.0 |
EV/EBITDA | 11.2 | 10.3 | 8.1 | 8.8 | 7.6 | 6.6 | 6.2 | 5.9 |
EV/EBIT (adj.) | 19.1 | 15.8 | 15.4 | 15.1 | 12.4 | 10.6 | 9.9 | 9.3 |
EV/EBIT | 26.4 | 18.5 | 40.1 | - | 14.8 | 11.7 | 10.7 | 10.1 |
P/E (adj.) | 19.3 | 15.9 | 11.7 | 14.4 | 13.4 | 11.4 | 10.7 | 10.1 |
P/E | 28.0 | 18.9 | 32.4 | - | 17.0 | 12.9 | 11.8 | 11.0 |
P/B | 2.2 | 2.5 | 1.3 | 1.9 | 2.0 | 1.8 | 1.7 | 1.5 |
P/S | 1.3 | 1.3 | 0.6 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 |
Dividend yield | 2.6 % | 2.4 % | 4.5 % | 3.9 % | 3.7 % | 3.9 % | 4.1 % | 4.3 % |
Equity ratio | 42.0 % | 42.0 % | 40.0 % | 36.3 % | 40.4 % | 43.9 % | 47.7 % | 51.6 % |
Gearing ratio | 85.9 % | 85.3 % | 95.7 % | 116.0 % | 92.2 % | 75.7 % | 60.7 % | 47.4 % |
Quarter data
Q2/23 | Q3/23 | Q4/23 | 2023 | Q1/24 | Q2/24e | Q3/24e | Q4/24e | 2024e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 322.4 | 280.5 | 342.5 | 1,286.5 | 350.2 | 331.5 | 292.4 | 358.1 | 1,332.1 |
EBITDA | 43.6 | 36.9 | 52.7 | 179.1 | 61.5 | 47.8 | 43.2 | 62.4 | 214.9 |
EBIT | 14.9 | 10.2 | -58.9 | -14.7 | 35.7 | 21.6 | 17.0 | 36.2 | 110.5 |
Profit before taxes | 9.7 | 3.7 | -66.5 | -38.9 | 29.6 | 14.4 | 9.8 | 29.0 | 82.8 |
Net income | 7.4 | 3.4 | -64.1 | -42.2 | 23.6 | 11.4 | 7.7 | 22.9 | 65.6 |
ShowingAll content types
Terveystalo Oyj: Terveystalo Group Interim Report January-March 2024: Strong performance driven by improved operational efficiency
Terveystalo Oyj: Terveystalo acquires SRK Group Oy, a provider of imaging services
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools